Business
SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America
SteinCares, a leading specialty healthcare company in Latin America, and Shilpa Biologicals Pvt. Ltd. (SBPL), a fully integrated biopharmaceutical subsidiary of Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), announce a strategic licensing agreement to commercialize a biosimilar across Latin America.
About this update from Shilpa Medicare Limited
[{"type":"list","items":[{"val":[{"type":"text","content":"New partnership combines Shilpa Biologicals' development and manufacturing capabilities with SteinCares' regional commercialization platform","length":148,"tagName":"p"}]},{"val":[{"type":"text","content":"Collaboration aims to expand patient access to cost-effective treatments and reinforces SteinCares' leadership in biosimilars across Latin America","length":150,"tagName":"p"}]},{"val":[{"type":"text","content":"Agreement marks the first product from this strategic partnership and Shilpa Biologicals' entry into the Latin American market","length":130,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":428,"olType":false},{"type":"text","content":"SAN JOSE, Costa Rica and RAICHUR, India, Feb. 25, 2026 /PRNewswire/ -- SteinCares, a leading specialty healthcare company in Latin America, and Shilpa Biologicals Pvt. Ltd. (SBPL), a fully integrated biopharmaceutical subsidiary of Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), announce a strategic licensing agreement to commercialize a biosimilar across Latin America.","length":380,"tagName":"p"},{"type":"image","alt":"Shilpa Medicare Limited Logo","displaySize":"","headline":null,"caption":"Shilpa Medicare Limited Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":126,"url":"https://media.zenfs.com/en/prnewswire.com/f939b94993067bbf4761a4f4b89263c3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/alvVE1_m1Bo0TFjZ51v.gg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIyMjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/f939b94993067bbf4761a4f4b89263c3","width":400,"height":126}}},{"type":"text","content":"Under the agreement, SteinCares will hold exclusive rights to register, commercialize, and distribute biosimilar across the region while SBPL will complete product development and commercial manufacturing from its facility in Dharwad, India. The partnership brings together SBPL's expertise in biologics development and high-quality commercial manufacturing with SteinCares' integrated regional platform.","length":412,"tagName":"p"},{"type":"text","content":""We are excited to partner with Shilpa Biologicals to bring this biosimilar to Latin America," said Mitchell Waserstein, CEO, SteinCares. "This agreement reinforces our leadership in biosimilars and our role...